Midatech Pharma Profile

USD 0.0263  3.81%

Midatech Pharma Summary

Midatech Pharma Plc (MTP) is traded on Nasdaq Capital Markets in USA. It is located in UNITED KINGDOM and employs 85 people. Midatech Pharma is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with total capitalization of 22.94 M. Midatech Pharma Plc runs under Healthcare sector within Pharmaceutical Products industry. This company has 48.72 M outstanding shares of which 26.79 K shares are now shorted by investors with about 0.09 days to cover shorted positions. MLP & STRATEGIC E has about 17.5 M in cash with (17.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.57.
Check Midatech Pharma Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 0.7163HorizonTargetOdds Above 0.7163
45.56%30 days 0.72 54.09%
Based on normal probability distribution, the odds of Midatech Pharma to move above current price in 30 days from now is about 54.09% (This Midatech Pharma Plc probability density function shows the probability of Midatech Pharma Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Susquehanna International Group LlpCommon Shares44.5 K36 K
Css LlcCommon Shares31.3 K26 K
View Midatech Pharma Diagnostics

Selected Midatech Pharma Plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Midatech Pharma Against Markets

Current Ratings

Midatech Pharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Midatech Pharma Plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom. Midatech Pharma operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 85 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameMidatech Pharma Plc
CEO, DirectorJames PhillipsView All
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
Business Address65 Innovation Drive
ExchangeNasdaq Capital Markets
IndustryPharmaceutical Products
Contact Number44 1235 888 300
CurrencyUSD - US Dollar

Diversify with Midatech Pharma Plc

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Midatech Pharma Plc to your portfolio


Midatech Pharma Corporate Directors
Simon Turton Senior Independent Non-executive Director
Nicholas RobbinsCherry Finance Director, Director, MBA
John Johnston Non-Executive Director
Please see also Stocks Correlation. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.